Trial Profile
Proof of Concept Study of the Safety and Immunogenicity of Influenza Virus Vaccine Fluzone 2004-2005 Among Healthy Children 2 Months vs 6 Months of Age.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 11 Mar 2009 New trial record